Cardinal Health To Acquire Cordis | 合法醫療器材資訊網

2015年3月2日—SignificantlyadvancesCardinalHealth'sofferingofinterventionalcardiologyandendovascularsolutionsforintegratedhealthsystemsand ...

- Significantly advances Cardinal Healths offering of interventional cardiology and endovascular solutions for integrated health systems and their patients

- Creates immediate global scale and scope

- Fiscal 2017, first full post-close year, accretion is expected to be greater than $0.20 in non-GAAP diluted earnings per share from continuing operations; increasingly accretive thereafter

DUBLIN, Ohio, March 2, 2015 /PRNewswire[1]/ -- Cardinal Health today announced plans to acquire Johnson & Johnsons Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.944 billion in cash, or approximately $1.594 billion, net of the present value of tax benefits. The acquisition is expected to be financed with a combination of $1.0 billion in new senior unsecured notes and the remainder with existing cash. The transaction is expected to close in t...